期刊文献+

前列地尔对脑血管造影术后造影剂肾病的预防研究 被引量:1

Research on alprostadil preventing contrast-induced nephropathy after cerebral angiography
下载PDF
导出
摘要 目的探讨前列地尔对脑血管造影术后造影剂肾病的预防作用及其使用方法。方法随机选择脑血管造影患者169例,分为对照组(49例)、前列地尔组(52例)、试验组(68例);对照组患者接受脑血管病二级预防治疗,前列地尔组患者在对照组基础上于术前给予患者静脉滴注1次10μg前列地尔,试验组患者在对照组基础上于术前给予患者静脉滴注2次10μg前列地尔,检测三组患者术前、术后连续3天及第5天的血清肌酐、胱抑素C水平,术前及术后72小时出现尿蛋白的例数。结果试验组和对照组患者术后第24、48、72小时及第5天血清肌酐、胱抑素C升高值比较差异有显著性(P<0.05);试验组和前列地尔组患者第48、72小时及第5天血清肌酐、胱抑素C升高值比较差异有显著性(P<0.05);术后尿蛋白发生情况,试验组与对照组、前列地尔组相比均有明显差异(P<0.05);前列地尔组和对照组第48、72小时血清肌酐、胱抑素C升高值比较差异有显著性(P<0.05)。结论行脑血管造影术前使用前列地尔注射液,能有效改善患者术后肾功能,降低术后造影剂肾病的发生率,具有较高的临床应用价值。 Objective To investigate the preventive effect of alprostadil on contrast-induced nephropathy after cerebral angiography and methods of use. Method 169 cases of patients underwent cerebral angiography were randomly divided into three groups, the control group(49 cases), alprostadil group(52 cases), and the experimental group(68 cases). Patients in the control group accepted therapy for secondary prevention of cerebrovascular disease, patients in the alprostadil group based on the control group, were given intravenous infusion of 10 μg alprostadil before surgery once, and the experimental group were intravenously administered 10 μg alprostadil twice on the basis of the control group, 3, 5 days, depending on the patient's condition decision. Three groups were detected before and after surgery for 3 days and 5 days of serum creatinine, cystatin C levels, preoperative and postoperative 72 hours appeared several cases of urinary protein. Result Experimental group and the control group patients and third five days 24, 48, 72 hours serum creatinine, cystatin C increased the value of the difference was significant(P〈0.05); alprostadil test group and 48 patients, 72 hours and the second five days of serum creatinine, cystatin C increased the value of the difference was statistically significant(P〈0.05); In the aspect of postoperative incidence of urinary protein test group and the control group, alprostadil group were significantly different(P〈0.05); alprostadil group and the control group at 48 and 72 hours in serum creatinine, cystatin C increased the value of the difference was statistically significant(P〈0.05). Conclusion Before the treatment of cerebral angiography using alprostadil, can effectively improve renal function, reduce the incidence of
出处 《中国医学前沿杂志(电子版)》 2014年第7期112-114,共3页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
关键词 前列地尔 脑血管造影 造影剂肾病 预防 Alprostadil Cerebral angiography Contrast nephropathy Prevention
  • 相关文献

参考文献11

二级参考文献59

共引文献67

同被引文献15

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部